Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration

Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration
Author :
Publisher :
Total Pages : 512
Release :
ISBN-10 : OSU:32437122474196
ISBN-13 :
Rating : 4/5 (96 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulation

Interagency Coordination in Drug Research and Regulation
Author :
Publisher :
Total Pages : 2010
Release :
ISBN-10 : MINN:31951D02159147Z
ISBN-13 :
Rating : 4/5 (7Z Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation by : United States. Congress. Senate. Committee on Government Operations. Subcommittee on Reorganization and International Organizations

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.

Interagency Coordination in Drug Research and Regulation

Interagency Coordination in Drug Research and Regulation
Author :
Publisher :
Total Pages : 1648
Release :
ISBN-10 : MINN:319510001092227
ISBN-13 :
Rating : 4/5 (27 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulations

Interagency Coordination in Drug Research and Regulations
Author :
Publisher :
Total Pages : 1332
Release :
ISBN-10 : STANFORD:36105117867023
ISBN-13 :
Rating : 4/5 (23 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulations by : United States. Congress. Senate. Government Operations

Interagency Coordination in Drug Research and Regulation

Interagency Coordination in Drug Research and Regulation
Author :
Publisher :
Total Pages : 332
Release :
ISBN-10 : IND:30000090845987
ISBN-13 :
Rating : 4/5 (87 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on specialized drugs and drug problems: 1) drugs for mental illness; 2) antibiotics; 3) drug testing; 4) neonatal pharmacology; and 5) communication on drug emergencies

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on specialized drugs and drug problems: 1) drugs for mental illness; 2) antibiotics; 3) drug testing; 4) neonatal pharmacology; and 5) communication on drug emergencies
Author :
Publisher :
Total Pages : 924
Release :
ISBN-10 : OSU:32437122474246
ISBN-13 :
Rating : 4/5 (46 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on specialized drugs and drug problems: 1) drugs for mental illness; 2) antibiotics; 3) drug testing; 4) neonatal pharmacology; and 5) communication on drug emergencies by : United States. Congress. Senate. Committee on Government Operations

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on: 1) Commission on Drug safety; 2) Pharmaceutical Manufacturers Association; 3) Medical education on drug therapy and other drug issues

Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on: 1) Commission on Drug safety; 2) Pharmaceutical Manufacturers Association; 3) Medical education on drug therapy and other drug issues
Author :
Publisher :
Total Pages : 728
Release :
ISBN-10 : OSU:32437122474295
ISBN-13 :
Rating : 4/5 (95 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation: Testimony and exhibits (including subsequent correspondence) on: 1) Commission on Drug safety; 2) Pharmaceutical Manufacturers Association; 3) Medical education on drug therapy and other drug issues by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulation

Interagency Coordination in Drug Research and Regulation
Author :
Publisher :
Total Pages : 884
Release :
ISBN-10 : CORNELL:31924000351837
ISBN-13 :
Rating : 4/5 (37 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration

Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration
Author :
Publisher :
Total Pages :
Release :
ISBN-10 : OCLC:82503435
ISBN-13 :
Rating : 4/5 (35 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration by : United States. Congress. Senate. Committee on Government Operations

Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2

Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2
Author :
Publisher :
Total Pages : 484
Release :
ISBN-10 : OSU:32437122474147
ISBN-13 :
Rating : 4/5 (47 Downloads)

Synopsis Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2 by : United States. Congress. Senate. Committee on Government Operations

Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.